Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck Spin-Off Prexton Turns mGluR4 Fortunes Around In Parkinson's Disease

Feb 07 2017

• By Sukaina Virji

Neurology

Related Content

Prexton Therapeutics

Sep 22 2015

Amgen acquires 'cheaper, oral' alternative to Repatha

Sep 16 2015

Merck hands back preclinical Parkinson's disease assets to Addex

Sep 05 2011

Forbion Closes Third Fund, 'Agnostic' On When To Invest

Apr 13 2016

Venture Funding Deals: ADC Therapeutics, Unity Biotech Raise $100m-Plus

Nov 11 2016

Domain and Merck Serono in Parkinson's alliance

Jan 17 2011

Addex founder launches first Swiss spin-out from Merck Serono

Jul 30 2012

Additional Topics

Financing Companies Commercial Neurology BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window